This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Circulation: CardiovascularInterventions, Ahead of Print. A generalized linear mixed model was used to evaluate risk-adjusted in-hospital/30-day mortality, 30-day heartfailure readmission, and TEER success (mitral regurgitation ≤2+ and gradient <5 mm Hg).RESULTS:The One-year mortality was 15.0%
Circulation: CardiovascularInterventions, Ahead of Print. Background:There are limited data about changes in cardiac function (cardiac reverse remodeling) and heartfailure indices after transcatheter tricuspid valve-in-valve replacement (TT-VIVR).
Circulation: CardiovascularInterventions, Ahead of Print. Health care costs and resource utilization (including all-cause hospitalizations, heartfailure hospitalizations and total inpatient days) were assessed for the AVR hospitalization and the following year.
Circulation: CardiovascularInterventions, Volume 18, Issue 3 , Page e014819, March 1, 2025. Over time more procedures were performed using only 1 implanted device (64.7% during 20222023 versus 54.6% during 20132017), without negatively impacting technical success.
Professor of Medicine at the Yale School of Medicine and Director of the Y ale New Haven Hospital Center for Outcomes Research and Evaluation. For more information: www.jacc.org If you enjoy this content, please share it with a colleague
Critical limb-threatening ischemia (CLTI) represents the end stage of peripheral artery disease (PAD), when poor circulation due to blockages in the arteries causes symptoms including numbness, sores that will not heal, gangrene, and extreme pain.
Circulation: CardiovascularInterventions, Ahead of Print. BACKGROUND:Patients with ST-segment–elevation myocardial infarction but no coronary microvascular injury are at low risk of early cardiovascular complications (ECC).
Critical limb-threatening ischemia (CLTI) represents the end stage of peripheral artery disease (PAD), when poor circulation due to blockages in the arteries causes symptoms including numbness, sores that will not heal, gangrene, and extreme pain.
Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)
Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content